{
  "meta": {
    "id": "test11",
    "title": "Neurocognitive Disorders",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 50-year-old man with no significant past medical history is admitted to the hospital following a hip fracture surgery. On the second day after surgery, his family reports that he has become increasingly fearful and disoriented. He appears to be fixated on the curtains in the room and insists that he sees \"strange creatures\" climbing on them. He also has fluctuating levels of consciousness and is agitated at times. Which of the following is the most likely diagnosis for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Delirium",
          "correct": true
        },
        {
          "label": "B",
          "text": "Dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Schizophrenia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute and transient psychotic disorder",
          "correct": false
        }
      ],
      "correct_answer": "A. Delirium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Delirium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Dementia is a chronic and progressive neurodegenerative disorder that typically presents with cognitive decline and memory impairment , rather than acute onset confusion and hallucinations.</li><li>\u2022 Option B. Dementia</li><li>\u2022 chronic and progressive neurodegenerative disorder</li><li>\u2022 presents with cognitive decline and memory impairment</li><li>\u2022 Option C. Schizophrenia can present with hallucinations and delusions . However, the acute onset of symptoms in the context of hip surgery and presence of disturbances of consciousness makes schizophrenia unlikely in this case.</li><li>\u2022 Option C. Schizophrenia</li><li>\u2022 hallucinations and delusions</li><li>\u2022 Option D. Acute and transient psychotic disorder is characterized by sudden onset psychotic symptoms , such as hallucinations and delusions , but the patient's presentation in the context of hip surgery and fluctuating levels of consciousness is more suggestive of delirium.</li><li>\u2022 Option D. Acute and transient psychotic disorder</li><li>\u2022 sudden onset psychotic symptoms</li><li>\u2022 hallucinations and delusions</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delirium is characterized by an acute onset of confusion, fluctuating levels of consciousness, and disturbances in attention and cognition . It is common in hospitalized patients , especially after surgery, and is distinguished by its reversible nature and the need for immediate medical attention to identify and treat the underlying cause.</li><li>\u27a4 Delirium</li><li>\u27a4 acute onset of confusion, fluctuating levels of consciousness, and disturbances in attention and cognition</li><li>\u27a4 common in hospitalized patients</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72b4ee76",
      "audio": ""
    },
    {
      "text": "A 75-year-old woman with a history of hypertension is admitted to the hospital for acute cholecystitis. On the second day of her hospital stay, she becomes increasingly confused, with periods of agitation and drowsiness. She is also experiencing perceptual disturbances and has difficulty focusing her attention. Which of the following symptoms is NOT typically associated with delirium?",
      "options": [
        {
          "label": "A",
          "text": "Fluctuating levels of consciousness",
          "correct": false
        },
        {
          "label": "B",
          "text": "Disorientation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gradual cognitive decline",
          "correct": true
        },
        {
          "label": "D",
          "text": "Visual hallucinations",
          "correct": false
        }
      ],
      "correct_answer": "C. Gradual cognitive decline",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-153910.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Gradual cognitive decline</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fluctuating levels of consciousness is a hallmark feature of delirium , with patients experiencing periods of agitation and drowsiness or hyperalertness and lethargy.</li><li>\u2022 Option A. Fluctuating levels of consciousness</li><li>\u2022 hallmark feature of delirium</li><li>\u2022 Option B. Disorientation , including to time, place, and person, is common in delirium and contributes to the confusion experienced by the patient.</li><li>\u2022 Option B. Disorientation</li><li>\u2022 time, place, and person, is common in delirium</li><li>\u2022 Option D. Visual hallucinations are often present in delirium and can contribute to the distress and confusion experienced by the patient.</li><li>\u2022 Option D. Visual hallucinations</li><li>\u2022 present in delirium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delirium is distinguished from dementia by its acute onset and fluctuating course.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 230.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 230.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "95e9b355",
      "audio": ""
    },
    {
      "text": "A 70-year-old man with a history of hypertension and diabetes is admitted to the hospital due to acute confusion and agitation. He is experiencing hallucinations, which are contributing to his agitation. Which of the following types of hallucinations is least likely to be associated with delirium?",
      "options": [
        {
          "label": "A",
          "text": "Visual hallucinations",
          "correct": false
        },
        {
          "label": "B",
          "text": "Auditory hallucinations",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tactile hallucinations",
          "correct": false
        },
        {
          "label": "D",
          "text": "Olfactory hallucinations",
          "correct": true
        }
      ],
      "correct_answer": "D. Olfactory hallucinations",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Olfactory hallucinations</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Visual hallucinations are the most common type of hallucinations in delirium . They are often complex and may involve seeing objects, people, or animals that are not present.</li><li>\u2022 Option A. Visual hallucinations</li><li>\u2022 most common type of hallucinations in delirium</li><li>\u2022 Option B. Auditory hallucinations can also occur in delirium , but they are less common than visual hallucinations.</li><li>\u2022 Option B. Auditory hallucinations</li><li>\u2022 occur in delirium</li><li>\u2022 Option C. Tactile hallucinations are less common than visual and auditory hallucinations in delirium but can still occur. Patients may report sensations of something crawling on their skin or other abnormal sensations.</li><li>\u2022 Option C. Tactile hallucinations</li><li>\u2022 less common than visual and auditory hallucinations in delirium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Visual and auditory hallucinations are more commonly associated with delirium than olfactory hallucinations . Delirium , particularly in elderly patients or those with underlying medical conditions, often presents with visual hallucinations, which can significantly contribute to the patient's confusion and agitation.</li><li>\u27a4 Visual and auditory hallucinations</li><li>\u27a4 commonly associated with delirium than olfactory hallucinations</li><li>\u27a4 Delirium</li><li>\u27a4 elderly patients</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "43654669",
      "audio": ""
    },
    {
      "text": "A 78-year-old man with a history of Parkinson's disease is admitted to the hospital for a scheduled hip replacement surgery. Postoperatively, he develops acute confusion, agitation, and disorientation. The medical team suspects delirium as the cause of his symptoms. Which neurotransmitter imbalance is most likely involved in the development of delirium in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Dopamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Serotonin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetylcholine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gamma-aminobutyric acid (GABA)",
          "correct": false
        }
      ],
      "correct_answer": "C. Acetylcholine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Acetylcholine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Dopamine is involved in various neuropsychiatric disorders , including Parkinson's disease and schizophrenia . However, it is not the primary neurotransmitter implicated in delirium.</li><li>\u2022 Option A. Dopamine</li><li>\u2022 various neuropsychiatric disorders</li><li>\u2022 Parkinson's disease and schizophrenia</li><li>\u2022 Option B. Serotonin is involved in mood regulation and can contribute to neuropsychiatric disorders , such as depression and anxiety . While it may play a role in the development of delirium, it is not the primary neurotransmitter involved.</li><li>\u2022 Option B. Serotonin</li><li>\u2022 mood regulation</li><li>\u2022 contribute to neuropsychiatric disorders</li><li>\u2022 depression and anxiety</li><li>\u2022 Option D. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a role in various neuropsychiatric disorders , including anxiety and epilepsy. However, it is not the primary neurotransmitter involved in delirium.</li><li>\u2022 Option D. Gamma-aminobutyric acid (GABA)</li><li>\u2022 inhibitory neurotransmitter that plays a role in various neuropsychiatric disorders</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delirium is associated with cholinergic deficiency , primarily involving the Ascending Reticular Activating System .</li><li>\u27a4 Delirium</li><li>\u27a4 cholinergic deficiency</li><li>\u27a4 Ascending Reticular Activating System</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f15732a3",
      "audio": ""
    },
    {
      "text": "A 74-year-old woman with a history of hypertension and osteoarthritis is admitted to the hospital for worsening confusion, agitation, and disorientation. The medical team suspects medication-induced delirium. Which class of medications is most likely to cause delirium in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Beta-blockers",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nonsteroidal anti-inflammatory drugs (NSAIDs)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anticholinergic medications",
          "correct": true
        },
        {
          "label": "D",
          "text": "Angiotensin-converting enzyme (ACE) inhibitors",
          "correct": false
        }
      ],
      "correct_answer": "C. Anticholinergic medications",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-155020.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Anticholinergic medications</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Beta-blockers are used to treat hypertension, angina, and arrhythmias . While they can cause central nervous system side effects, they are not the primary class of medications associated with delirium.</li><li>\u2022 Option A. Beta-blockers</li><li>\u2022 treat hypertension, angina, and arrhythmias</li><li>\u2022 Option B. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat pain and inflammation. While they can cause gastrointestinal, renal, and cardiovascular side effects, they are not the primary class of medications associated with delirium.</li><li>\u2022 Option B. Nonsteroidal anti-inflammatory drugs (NSAIDs)</li><li>\u2022 treat pain and inflammation.</li><li>\u2022 Option D. Angiotensin-converting enzyme (ACE) inhibitors are used to treat hypertension and heart failure. While they can cause side effects like cough, hyperkalemia, and renal dysfunction, they are not the primary class of medications associated with delirium.</li><li>\u2022 Option D. Angiotensin-converting enzyme (ACE) inhibitors</li><li>\u2022 treat hypertension and heart failure.</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective :</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 232.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 232.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0bc9d383",
      "audio": ""
    },
    {
      "text": "A 75-year-old man is admitted to the hospital with pneumonia. The nursing staff reports that the patient is having episodes of confusion, agitation, and disorientation. The medical team wants to assess the patient for delirium. Which of the following screening tools is commonly used to identify delirium in hospitalized patients?",
      "options": [
        {
          "label": "A",
          "text": "Confusion Assessment Method (CAM)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mini-Mental State Examination (MMSE)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hamilton Rating Scale for Depression (HAM-D)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Montreal Cognitive Assessment (MoCA)",
          "correct": false
        }
      ],
      "correct_answer": "A. Confusion Assessment Method (CAM)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Confusion Assessment Method (CAM)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. The Mini-Mental State Examination (MMSE) is a cognitive screening tool that assesses various aspects of cognitive function, including orientation, memory, attention, and language. While it may be useful in evaluating the severity of cognitive impairment, it is not specifically designed to diagnose delirium.</li><li>\u2022 Option B. The Mini-Mental State Examination (MMSE)</li><li>\u2022 cognitive screening tool</li><li>\u2022 cognitive function, including orientation, memory, attention, and language.</li><li>\u2022 Option C. The Hamilton Rating Scale for Depression (HAM-D) is a clinician-administered questionnaire used to assess the severity of depressive symptoms in patients. It is not used to screen for delirium.</li><li>\u2022 Option C. The Hamilton Rating Scale for Depression (HAM-D)</li><li>\u2022 clinician-administered questionnaire</li><li>\u2022 Option D. The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening tool that evaluates multiple cognitive domains , including memory, attention, language , and executive function . While it may be useful in detecting mild cognitive impairment and early dementia, it is not specifically designed to diagnose delirium.</li><li>\u2022 Option D. The Montreal Cognitive Assessment (MoCA)</li><li>\u2022 cognitive screening tool that evaluates multiple cognitive domains</li><li>\u2022 memory, attention, language</li><li>\u2022 executive function</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Confusion Assessment Method (CAM) is a tool specifically developed to detect delirium . Bedside examinations such as mini mental status examination (MMSE) are used to provide a measure of cognitive impairment .</li><li>\u27a4 Confusion Assessment Method</li><li>\u27a4 tool specifically developed to detect delirium</li><li>\u27a4 mini mental status examination (MMSE)</li><li>\u27a4 measure of cognitive impairment</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 229.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 229.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "616ee5a8",
      "audio": ""
    },
    {
      "text": "A 75-year-old woman with a history of hypertension and type 2 diabetes mellitus presents to the clinic with her daughter. The daughter reports that over the past year, her mother has been increasingly forgetful, losing items, and repeating questions. The patient has also been having difficulty managing her finances. Which of the following conditions is most likely causing the patient's symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease",
          "correct": true
        },
        {
          "label": "B",
          "text": "Frontotemporal dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vascular dementia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lewy body dementia",
          "correct": false
        }
      ],
      "correct_answer": "A. Alzheimer's disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Alzheimer's disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Frontotemporal dementia typically presents with changes in personality and behavior , rather than memory loss, which is the primary concern in this case.</li><li>\u2022 Option B. Frontotemporal dementia</li><li>\u2022 presents with changes in personality and behavior</li><li>\u2022 Option C. Vascular dementia is often associated with a history of cerebrovascular accidents or cardiovascular risk factors . However, the gradual onset of memory loss and cognitive decline in this patient is more consistent with Alzheimer's disease.</li><li>\u2022 Option C. Vascular dementia</li><li>\u2022 associated with a history of cerebrovascular accidents or cardiovascular risk factors</li><li>\u2022 Option D. Lewy body dementia usually presents with fluctuating cognitive impairment, visual hallucinations, and Parkinsonian features . The clinical presentation in this case is more suggestive of Alzheimer's disease.</li><li>\u2022 Option D. Lewy body dementia</li><li>\u2022 fluctuating cognitive impairment, visual hallucinations, and Parkinsonian features</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presentation of progressive memory impairment , particularly in short-term memory, and difficulty with complex tasks such as managing finances in an elderly patient is most suggestive of Alzheimer's disease , the most common cause of dementia.</li><li>\u27a4 progressive memory impairment</li><li>\u27a4 short-term memory, and difficulty with complex</li><li>\u27a4 managing finances in an elderly patient</li><li>\u27a4 Alzheimer's disease</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 242.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 242.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "866d8792",
      "audio": ""
    },
    {
      "text": "A 68-year-old man presents to the clinic with his wife, who reports that he has been experiencing progressive memory loss, confusion, and spatial disorientation over the past six months. His symptoms have become severe enough to interfere with his daily activities. A brain MRI reveals atrophy of the medial temporal lobes. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease",
          "correct": true
        },
        {
          "label": "B",
          "text": "Vascular dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Frontotemporal dementia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lewy body dementia",
          "correct": false
        }
      ],
      "correct_answer": "A. Alzheimer's disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Alzheimer's disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Vascular dementia typically presents with a stepwise decline in cognitive function, often related to a history of cerebrovascular accidents or cardiovascular risk factors . The clinical presentation and MRI findings in this case are more suggestive of Alzheimer's disease.</li><li>\u2022 Option B. Vascular dementia</li><li>\u2022 stepwise decline in cognitive function,</li><li>\u2022 cerebrovascular accidents or cardiovascular risk factors</li><li>\u2022 Option C. Frontotemporal dementia usually presents with changes in personality & behavior , rather than memory loss and spatial disorientation, as seen in this patient.</li><li>\u2022 Option C. Frontotemporal dementia</li><li>\u2022 changes in personality & behavior</li><li>\u2022 Option D. Lewy body dementia is characterized by fluctuating cognitive impairment, visual hallucinations, and Parkinsonian features . The clinical presentation and MRI findings in this case are more consistent with Alzheimer's disease.</li><li>\u2022 Option D. Lewy body dementia</li><li>\u2022 fluctuating cognitive impairment, visual hallucinations, and Parkinsonian features</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Progressive memory loss , confusion , and spatial disorientation in an elderly patient , coupled with MRI findings of medial temporal lobe atrophy , strongly suggest Alzheimer's disease . Alzheimer's disease is characterized by the gradual onset and progressive worsening of memory and other cognitive functions, with medial temporal lobe atrophy being a common neuroimaging finding.</li><li>\u27a4 Progressive memory loss</li><li>\u27a4 confusion</li><li>\u27a4 spatial disorientation in an elderly patient</li><li>\u27a4 coupled with MRI findings</li><li>\u27a4 medial temporal lobe atrophy</li><li>\u27a4 Alzheimer's disease</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 242.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 242.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6981469b",
      "audio": ""
    },
    {
      "text": "A 60-year-old woman presents to the clinic with a one-year history of progressive memory loss, difficulty finding words, and difficulty completing daily tasks. Her family history reveals her mother had a similar condition in her late sixties. The patient is diagnosed with mild Alzheimer's disease. Which of the following medications is the most appropriate initial treatment?",
      "options": [
        {
          "label": "A",
          "text": "Memantine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Donepezil",
          "correct": true
        },
        {
          "label": "C",
          "text": "Risperidone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Haloperidol",
          "correct": false
        }
      ],
      "correct_answer": "B. Donepezil",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Donepezil</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist that is used to treat moderate to severe Alzheimer's disease . It is not the first-line treatment for mild Alzheimer's disease.</li><li>\u2022 Option A. Memantine</li><li>\u2022 N-methyl-D-aspartate</li><li>\u2022 receptor antagonist</li><li>\u2022 treat moderate to severe Alzheimer's disease</li><li>\u2022 Option C. Risperidone and D. Haloperidol are antipsychotic medications that might be used to manage behavioral symptoms such as agitation, aggression, or psychosis in Alzheimer's disease patients . However, they are not the first-line treatment for the cognitive symptoms associated with mild Alzheimer's disease</li><li>\u2022 Option C. Risperidone</li><li>\u2022 D. Haloperidol</li><li>\u2022 antipsychotic medications</li><li>\u2022 manage behavioral symptoms such as agitation, aggression, or psychosis in Alzheimer's disease patients</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Donepezil , a cholinesterase inhibitor , is a common initial treatment for mild to moderate Alzheimer's disease . It works by increasing acetylcholine levels in the brain , which can help improve cognitive function in patients with Alzheimer's disease . Other cholinesterase inhibitors include rivastigmine and galantamine. Memantine is used in moderate to severe Alzheimer's disease and can be combined with cholinesterase inhibitors in some cases. Antipsychotics like risperidone and haloperidol are not first-line treatments for Alzheimer's disease and are used to manage behavioral symptoms, not cognitive decline.</li><li>\u2022 Donepezil</li><li>\u2022 cholinesterase inhibitor</li><li>\u2022 initial treatment for mild to moderate Alzheimer's disease</li><li>\u2022 increasing acetylcholine levels in the brain</li><li>\u2022 improve cognitive function in patients with Alzheimer's disease</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a27055ce",
      "audio": ""
    },
    {
      "text": "All of the following are types of cortical dementias, except:",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Frontotemporal dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lewy body dementia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Huntington's disease",
          "correct": true
        }
      ],
      "correct_answer": "D. Huntington's disease",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-162329.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Huntington's disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alzheimer's disease and B. Frontotemporal dementia are examples of cortical dementias . In cortical dementias , the damage is primarily in the brain's cortical areas , leading to symptoms such as aphasia (language difficulties), agnosia (difficulty recognizing objects), and memory loss.</li><li>\u2022 Option A. Alzheimer's disease</li><li>\u2022 B. Frontotemporal dementia</li><li>\u2022 cortical dementias</li><li>\u2022 cortical dementias</li><li>\u2022 damage is primarily in the brain's cortical areas</li><li>\u2022 Option C. Lewy body dementia can present with features of both cortical and subcortical dementia , due to the widespread distribution of Lewy bodies in both cortical and subcortical structures . However, it is often grouped with cortical dementias because of its significant impact on cortical functions, such as cognitive and perceptual abilities.</li><li>\u2022 Option C. Lewy body dementia</li><li>\u2022 features of both cortical and subcortical dementia</li><li>\u2022 widespread distribution of Lewy bodies</li><li>\u2022 both cortical and subcortical structures</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 244.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 244.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4e03b97",
      "audio": ""
    },
    {
      "text": "All of the following are types of subcortical dementia, except:",
      "options": [
        {
          "label": "A",
          "text": "Progressive supranuclear palsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Huntington's disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Parkinson's disease dementia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Creutzfeldt-Jakob disease",
          "correct": true
        }
      ],
      "correct_answer": "D. Creutzfeldt-Jakob disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Creutzfeldt-Jakob disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Progressive supranuclear palsy, Option B. Huntington's disease, and Option C. Parkinson's disease dementia are examples of subcortical dementias. These conditions primarily affect the parts of the brain below the cortex , such as the basal ganglia, thalamus, and brainstem , leading to symptoms that differ from those seen in cortical dementias. Subcortical dementias are often characterized by changes in the speed of cognitive processing, attention, and executive function, rather than the aphasia, agnosia, and pronounced memory deficits more typical of cortical dementias.</li><li>\u2022 Option A. Progressive supranuclear palsy, Option B. Huntington's disease, and Option C. Parkinson's disease dementia</li><li>\u2022 subcortical dementias.</li><li>\u2022 affect the parts of the brain below the cortex</li><li>\u2022 basal ganglia, thalamus, and brainstem</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Subcortical dementias are characterized by degeneration in the areas of the brain below the cortex , leading to symptoms such as slowed cognitive processing, attention deficits , and executive dysfunction . Examples include progressive supranuclear palsy, Huntington's disease, and Parkinson's disease dementia. Creutzfeldt-Jakob disease, although it causes dementia and involves subcortical structures, is not classified purely as a subcortical dementia due to its significant cortical involvement and widespread effects across the brain.</li><li>\u27a4 Subcortical dementias</li><li>\u27a4 degeneration in the areas of the brain</li><li>\u27a4 below the cortex</li><li>\u27a4 slowed cognitive processing, attention deficits</li><li>\u27a4 executive dysfunction</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 244.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 244.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "43fcc88c",
      "audio": ""
    },
    {
      "text": "Which of the following statements regarding Alzheimer's disease is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease has a higher prevalence among females than males.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insight is typically lost early in the progression of Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "C",
          "text": "The majority of Alzheimer's disease cases are of familial origin.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Late-onset Alzheimer's disease represents the majority of cases.",
          "correct": false
        }
      ],
      "correct_answer": "C. The majority of Alzheimer's disease cases are of familial origin.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) The majority of Alzheimer's disease cases are of familial origin.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alzheimer's disease has a higher prevalence among females than males - True . This is likely due to a combination of factors, including women's longer life expectancy.</li><li>\u2022 Option A. Alzheimer's disease has a higher prevalence among females than males -</li><li>\u2022 True</li><li>\u2022 Option B. Insight is typically lost early in the progression of Alzheimer's disease - True . Patients often lose awareness of their cognitive decline early in the disease process.</li><li>\u2022 Option B. Insight is typically lost early in the progression of Alzheimer's disease -</li><li>\u2022 True</li><li>\u2022 Option D. Late-onset Alzheimer's disease represents the majority of cases - True . Late-onset Alzheimer's disease, typically occurring after the age of 65, is the most common form of the disorder.</li><li>\u2022 Option D. Late-onset Alzheimer's disease represents the majority of cases -</li><li>\u2022 True</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The majority of Alzheimer's disease (AD) cases are sporadic, meaning they occur at random without a clear familial pattern . Only a small percentage of AD cases, estimated at around 1% to 5%, are truly familial , resulting from genetic mutations in specific genes (such as APP, PSEN1, and PSEN2) that are inherited in an autosomal dominant manner. These familial cases often present as early-onset AD, which occurs before the age of 65.</li><li>\u2022 majority of Alzheimer's disease</li><li>\u2022 cases are sporadic,</li><li>\u2022 occur at random without a clear familial pattern</li><li>\u2022 1% to 5%, are truly familial</li><li>\u2022 genetic mutations in specific genes</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239-240.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239-240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a32a9d95",
      "audio": ""
    },
    {
      "text": "Which of the following statements about the pathophysiology of Alzheimer's disease is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Accumulation of extracellular amyloid-beta plaques contributes to neuronal dysfunction.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intracellular neurofibrillary tangles are composed primarily of hyperphosphorylated tau protein.",
          "correct": false
        },
        {
          "label": "C",
          "text": "The presence of the APOE \u03b54 allele increases the risk of developing late-onset Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The primary mechanism of Alzheimer's disease is the loss of dopaminergic neurons in the substantia nigra.",
          "correct": true
        }
      ],
      "correct_answer": "D. The primary mechanism of Alzheimer's disease is the loss of dopaminergic neurons in the substantia nigra.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) The primary mechanism of Alzheimer's disease is the loss of dopaminergic neurons in the substantia nigra.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Accumulation of extracellular amyloid-beta plaques contributes to neuronal dysfunction: This statement is true . One of the hallmark pathological features of AD is the accumulation of extracellular amyloid-beta (A\u03b2) plaques, which contribute to neuronal dysfunction and death.</li><li>\u2022 Option A. Accumulation of extracellular amyloid-beta plaques contributes to neuronal dysfunction:</li><li>\u2022 true</li><li>\u2022 Option B. Intracellular neurofibrillary tangles are composed primarily of hyperphosphorylated tau protein: This statement is true . Another hallmark feature of AD is the presence of intracellular neurofibrillary tangles, which are composed of hyperphosphorylated tau protein. These tangles disrupt the normal function of neurons and contribute to their degeneration.</li><li>\u2022 Option B. Intracellular neurofibrillary tangles are composed primarily of hyperphosphorylated tau protein:</li><li>\u2022 true</li><li>\u2022 Option C. The presence of the APOE \u03b54 allele increases the risk of developing late-onset Alzheimer's disease: This statement is true . The APOE \u03b54 allele is the most significant genetic risk factor for late-onset AD. Individuals carrying one or two copies of the \u03b54 allele have an increased risk of developing the disease, although having the allele does not guarantee that a person will develop AD.</li><li>\u2022 Option C. The presence of the APOE \u03b54 allele increases the risk of developing late-onset Alzheimer's disease:</li><li>\u2022 true</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The pathophysiology of Alzheimer's disease involves the accumulation of extracellular amyloid-beta plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein , leading to neuronal dysfunction and death. The APOE \u03b54 allele is a genetic risk factor for late-onset Alzheimer's disease.It is associated with loss of cholinergic neurons in nucleus basalis of Meynert.</li><li>\u27a4 pathophysiology of Alzheimer's disease</li><li>\u27a4 accumulation of extracellular amyloid-beta plaques</li><li>\u27a4 intracellular neurofibrillary tangles</li><li>\u27a4 hyperphosphorylated tau protein</li><li>\u27a4 neuronal dysfunction and death.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3bfbc543",
      "audio": ""
    },
    {
      "text": "A 75-year-old woman is diagnosed with Alzheimer's disease after a thorough clinical evaluation. The amyloid cascade hypothesis has been proposed as a possible mechanism for the pathogenesis of this disease. Which of the following statements most accurately describes the amyloid cascade hypothesis?",
      "options": [
        {
          "label": "A",
          "text": "Decreased production of beta-amyloid leads to the formation of neurofibrillary tangles.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Accumulation of beta-amyloid triggers a cascade of events leading to neuronal damage and cognitive decline.",
          "correct": true
        },
        {
          "label": "C",
          "text": "The buildup of alpha-synuclein in neurons results in the formation of amyloid plaques.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The hyperphosphorylation of tau protein results in the accumulation of amyloid plaques.",
          "correct": false
        }
      ],
      "correct_answer": "B. Accumulation of beta-amyloid triggers a cascade of events leading to neuronal damage and cognitive decline.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-163849.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Accumulation of beta-amyloid triggers a cascade of events leading to neuronal damage and cognitive decline.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Decreased production of beta-amyloid leads to the formation of neurofibrillary tangles: This statement is incorrect. The amyloid cascade hypothesis focuses on the accumulation of beta-amyloid, not its decrease, as a key event in Alzheimer's disease pathogenesis. The relationship between A\u03b2 accumulation and the formation of neurofibrillary tangles involves complex interactions, but decreased A\u03b2 production is not the proposed mechanism.</li><li>\u2022 Option A. Decreased production of beta-amyloid leads to the formation of neurofibrillary tangles:</li><li>\u2022 incorrect.</li><li>\u2022 amyloid cascade hypothesis</li><li>\u2022 accumulation of beta-amyloid, not its decrease,</li><li>\u2022 Option C. The buildup of alpha-synuclein in neurons results in the formation of amyloid plaques: This statement is incorrect in the context of Alzheimer's disease. Alpha-synuclein accumulation is associated with Parkinson's disease and other synucleinopathies, where it forms Lewy bodies , not amyloid plaques. Amyloid plaques in Alzheimer's disease are primarily composed of beta-amyloid peptides.</li><li>\u2022 Option C. The buildup of alpha-synuclein in neurons results in the formation of amyloid plaques:</li><li>\u2022 incorrect</li><li>\u2022 Alpha-synuclein accumulation is associated with Parkinson's disease and other synucleinopathies, where it forms Lewy bodies</li><li>\u2022 Option D. The hyperphosphorylation of tau protein results in the accumulation of amyloid plaques: This statement is incorrect . While hyperphosphorylated tau protein does form the intracellular neurofibrillary tangles observed in Alzheimer's disease , it is not responsible for the accumulation of amyloid plaques . The amyloid plaques are formed from beta-amyloid peptides, and the relationship between tau pathology and amyloid pathology is an area of ongoing research.</li><li>\u2022 Option D. The hyperphosphorylation of tau protein results in the accumulation of amyloid plaques:</li><li>\u2022 incorrect</li><li>\u2022 hyperphosphorylated tau protein</li><li>\u2022 form the intracellular neurofibrillary tangles observed in Alzheimer's disease</li><li>\u2022 not responsible for the accumulation of amyloid plaques</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The amyloid cascade hypothesis can be summarized in a stepwise manner as shown below</li><li>\u27a4 Ref: Shorter Textbook of Psychiatry, 7th edition, Page 364.</li><li>\u27a4 Ref:</li><li>\u27a4 Shorter Textbook of Psychiatry, 7th edition, Page 364.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "41711eea",
      "audio": ""
    },
    {
      "text": "A 40-year-old man presents to the clinic with concerns about his risk of developing early-onset Alzheimer's disease (EOAD). His father was diagnosed with Alzheimer's disease at the age of 55, and his paternal grandfather also exhibited memory problems in his early 50s. The patient is worried about the possibility of having a genetic predisposition to EOAD. Which of the following statements is true regarding the genetics of early-onset familial Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "The majority of early-onset Alzheimer's disease cases are caused by mutations in the APOE gene.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mutations in the amyloid precursor protein (APP) gene, presenilin-1 (PSEN1) gene, and presenilin-2 (PSEN2) gene are strongly associated with early-onset familial Alzheimer's disease.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Genetic testing for early-onset Alzheimer's disease is typically recommended for all individuals with a family history of dementia.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The risk of developing early-onset Alzheimer's disease is primarily determined by environmental factors, rather than genetics.",
          "correct": false
        }
      ],
      "correct_answer": "B. Mutations in the amyloid precursor protein (APP) gene, presenilin-1 (PSEN1) gene, and presenilin-2 (PSEN2) gene are strongly associated with early-onset familial Alzheimer's disease.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-164413.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-164502.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Mutations in the amyloid precursor protein (APP) gene, presenilin-1 (PSEN1) gene, and presenilin-2 (PSEN2) gene are strongly associated with early-onset familial Alzheimer's disease.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. The majority of early-onset Alzheimer's disease cases are caused by mutations in the APOE gene: This statement is incorrect . While the APOE \u03b54 allele is a well-known risk factor for late-onset Alzheimer's disease (typically presenting after age 65), it is not the cause of the majority of early-onset cases . Early-onset familial Alzheimer's disease is more closely associated with mutations in the APP, PSEN1, and PSEN2 genes.</li><li>\u2022 Option A. The majority of early-onset Alzheimer's disease cases are caused by mutations in the APOE gene:</li><li>\u2022 incorrect</li><li>\u2022 APOE \u03b54 allele is a well-known risk factor for late-onset Alzheimer's disease</li><li>\u2022 not the cause of the majority of early-onset cases</li><li>\u2022 Option C. Genetic testing for early-onset Alzheimer's disease is typically recommended for all individuals with a family history of dementia: This statement is overly broad . Genetic testing may be considered in individuals with a strong family history of early-onset Alzheimer's disease , especially when multiple family members are affected at an early age . However, the decision to undergo genetic testing should involve careful consideration and counseling due to the potential psychological and ethical implications.</li><li>\u2022 Option C. Genetic testing for early-onset Alzheimer's disease is typically recommended for all individuals with a family history of dementia:</li><li>\u2022 overly broad</li><li>\u2022 Genetic testing may be considered in individuals with a strong family history of early-onset Alzheimer's disease</li><li>\u2022 multiple family members are affected at an early age</li><li>\u2022 Option D. The risk of developing early-onset Alzheimer's disease is primarily determined by environmental factors, rather than genetics: This statement is incorrect . While environmental factors can play a role in the risk of developing Alzheimer's disease, early-onset familial Alzheimer's disease is strongly influenced by specific genetic mutations .</li><li>\u2022 Option D. The risk of developing early-onset Alzheimer's disease is primarily determined by environmental factors, rather than genetics:</li><li>\u2022 incorrect</li><li>\u2022 early-onset familial Alzheimer's disease is strongly influenced by specific genetic mutations</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239-240.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239-240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e85b724",
      "audio": ""
    },
    {
      "text": "A 52-year-old woman presents to the clinic with her daughter, concerned about the possibility of developing Alzheimer's disease (AD). The patient's mother was diagnosed with AD at the age of 70, and she recently read about a genetic link to the disease. Which of the following statements is true regarding the genetics of Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "Mutations in the APOE gene are the primary cause of early-onset Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Familial Alzheimer's disease accounts for the majority of Alzheimer's cases.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Late-onset Alzheimer's disease is strongly associated with mutations in the APP gene.",
          "correct": false
        },
        {
          "label": "D",
          "text": "The presence of an APOE \u03b54 allele increases the risk of developing late-onset Alzheimer's disease.",
          "correct": true
        }
      ],
      "correct_answer": "D. The presence of an APOE \u03b54 allele increases the risk of developing late-onset Alzheimer's disease.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) The presence of an APOE \u03b54 allele increases the risk of developing late-onset Alzheimer's disease.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Mutations in the APOE gene are the primary cause of early-onset Alzheimer's disease: This statement is incorrect . Mutations in the APOE gene , specifically the \u03b54 allele, are associated with an increased risk of late-onset Alzheimer's disease , not early-onset Alzheimer's disease (EOAD). EOAD, which occurs before the age of 65, is more commonly associated with mutations in the APP, PSEN1, and PSEN2 genes.</li><li>\u2022 Option A. Mutations in the APOE gene are the primary cause of early-onset Alzheimer's disease:</li><li>\u2022 incorrect</li><li>\u2022 Mutations in the APOE gene</li><li>\u2022 \u03b54 allele, are associated with an increased risk of late-onset Alzheimer's disease</li><li>\u2022 Option B. Familial Alzheimer's disease accounts for the majority of Alzheimer's cases: This statement is incorrect . Familial Alzheimer's disease, which is caused by genetic mutations, accounts for a small percentage of all Alzheimer's cases, estimated at 1% to 5%. The majority of Alzheimer's disease cases are sporadic and have a more complex etiology involving both genetic and environmental factors.</li><li>\u2022 Option B. Familial Alzheimer's disease accounts for the majority of Alzheimer's cases:</li><li>\u2022 incorrect</li><li>\u2022 caused by genetic mutations, accounts for a small percentage of all Alzheimer's cases, estimated at 1% to 5%.</li><li>\u2022 Option C. Late-onset Alzheimer's disease is strongly associated with mutations in the APP gene: This statement is incorrect . While mutations in the amyloid precursor protein (APP) gene are associated with some cases of early-onset familial Alzheimer's disease , they are not commonly associated with late-onset Alzheimer's disease. The APP gene mutations lead to the production of abnormal amyloid-beta peptides, which are central to the pathogenesis of Alzheimer's disease, but these mutations are not typically involved in late-onset cases.</li><li>\u2022 Option C. Late-onset Alzheimer's disease is strongly associated with mutations in the APP gene:</li><li>\u2022 incorrect</li><li>\u2022 mutations in the amyloid precursor protein</li><li>\u2022 gene are associated with some cases of early-onset familial Alzheimer's disease</li><li>\u2022 not commonly associated with late-onset Alzheimer's disease.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of the APOE \u03b54 allele is a significant genetic risk factor for late-onset Alzheimer's disease , increasing the risk of developing the disease but not guaranteeing it . Early-onset Alzheimer's disease, which is less common, is associated with mutations in the APP, PSEN1, and PSEN2 genes. Familial Alzheimer's disease accounts for a small percentage of all cases, with the majority being sporadic.</li><li>\u27a4 presence of the APOE \u03b54 allele is a significant genetic risk factor for late-onset Alzheimer's disease</li><li>\u27a4 increasing the risk of developing the disease but not guaranteeing it</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "46a451fa",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman is concerned about her risk of developing Alzheimer's disease, as her mother was diagnosed with the condition in her late 70s. She is seeking advice on modifiable risk factors to help lower her risk. Which of the following factors is NOT associated with an increased risk of Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "Hyperlipidemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type 2 diabetes mellitus",
          "correct": false
        },
        {
          "label": "C",
          "text": "High educational attainment",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sleep apnea",
          "correct": false
        }
      ],
      "correct_answer": "C. High educational attainment",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-165124.jpg"
      ],
      "explanation": "<p><strong>Ans. C) High educational attainment</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hyperlipidemia: Elevated cholesterol levels , particularly low-density lipoprotein (LDL) cholesterol , are associated with an increased risk of Alzheimer's disease .</li><li>\u2022 Option A. Hyperlipidemia:</li><li>\u2022 Elevated cholesterol levels</li><li>\u2022 low-density lipoprotein</li><li>\u2022 cholesterol</li><li>\u2022 increased risk of Alzheimer's disease</li><li>\u2022 Option B. Type 2 diabetes mellitus: Studies have demonstrated a connection between type 2 diabetes and an increased risk of Alzheimer's disease , possibly due to insulin resistance and inflammation.</li><li>\u2022 Option B. Type 2 diabetes mellitus:</li><li>\u2022 connection between type 2 diabetes and an increased risk of Alzheimer's disease</li><li>\u2022 Option D. Sleep apnea: Sleep apnea and other sleep disturbances have been linked to an increased risk of Alzheimer's disease , potentially due to the disruption of normal sleep patterns and the resulting impact on brain health.</li><li>\u2022 Option D. Sleep apnea:</li><li>\u2022 sleep disturbances have been linked to an increased risk of Alzheimer's disease</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective :</li><li>\u2022 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li><li>\u2022 Ref:</li><li>\u2022 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c1a9584b",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman with a known diagnosis of Alzheimer's disease presents to the clinic with her caregiver, who reports the patient has been experiencing visual hallucinations for the past month. The caregiver is concerned about these symptoms and their impact on the patient's quality of life. Which of the following statements is true regarding the use of antipsychotics in the management of behavioral and psychological symptoms of dementia (BPSD)?",
      "options": [
        {
          "label": "A",
          "text": "Antipsychotics are the first-line treatment for BPSD in Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Antipsychotics have no significant side effects in the elderly population with dementia.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Antipsychotics have a black box warning for increased mortality in elderly patients with dementia.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antipsychotics are contraindicated in Alzheimer's disease.",
          "correct": false
        }
      ],
      "correct_answer": "C. Antipsychotics have a black box warning for increased mortality in elderly patients with dementia.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Antipsychotics have a black box warning for increased mortality in elderly patients with dementia.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Antipsychotics are not considered first-line treatment for BPSD in Alzheimer's disease . Non-pharmacological interventions are usually tried first , and antipsychotics are reserved for severe cases or when other treatments have failed.</li><li>\u2022 Option A.</li><li>\u2022 Antipsychotics are not considered first-line treatment for BPSD in Alzheimer's disease</li><li>\u2022 Non-pharmacological interventions</li><li>\u2022 tried first</li><li>\u2022 antipsychotics are reserved for severe cases</li><li>\u2022 Option B. Antipsychotics can have significant side effects in the elderly population with dementia , including an increased risk of falls, sedation, and extrapyramidal symptoms .</li><li>\u2022 Option B.</li><li>\u2022 Antipsychotics can have significant side effects in the elderly population with dementia</li><li>\u2022 increased risk of falls, sedation, and extrapyramidal symptoms</li><li>\u2022 Option D. Although antipsychotics are not contraindicated in Alzheimer's disease , their use should be carefully considered due to the associated risks and potential side effects . They should only be used when other interventions have failed and the potential benefits outweigh the risks. This warning was issued by the FDA due to the increased risk of death associated with the use of these medications in this population. The increased mortality is mainly due to cardiovascular events (e.g., heart failure, sudden death) and infections (e.g., pneumonia).</li><li>\u2022 Option D.</li><li>\u2022 antipsychotics are not contraindicated in Alzheimer's disease</li><li>\u2022 use should be carefully considered due to the associated risks and potential side effects</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Antipsychotic medications carry a black box warning for an increased risk of mortality when used in elderly patients with dementia-related psychosis . Their use in managing behavioral and psychological symptoms of dementia should be considered cautiously , only after nonpharmacological interventions have been tried and deemed ineffective , and should be limited to the lowest effective dose for the shortest necessary duration.</li><li>\u27a4 Antipsychotic medications carry a black box warning for an increased risk of mortality</li><li>\u27a4 elderly patients with dementia-related psychosis</li><li>\u27a4 managing behavioral and psychological symptoms of dementia should be considered cautiously</li><li>\u27a4 nonpharmacological interventions have been tried and deemed ineffective</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ea67d4b",
      "audio": ""
    },
    {
      "text": "A 74-year-old woman is brought to the clinic by her daughter, who is concerned about her mother's progressive memory loss and confusion over the past year. The patient has difficulty recalling recent events and has become increasingly disoriented. Her daughter also reports that her mother has been struggling to manage her daily activities, such as cooking and shopping. The physician decides to perform a cognitive assessment. Which of the following components would be assessed using the Mini-Mental State Examination (MMSE) in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Hallucinations and delusions",
          "correct": false
        },
        {
          "label": "B",
          "text": "Motor coordination and strength",
          "correct": false
        },
        {
          "label": "C",
          "text": "Orientation, recall, and language",
          "correct": true
        },
        {
          "label": "D",
          "text": "Executive function and problem-solving",
          "correct": false
        }
      ],
      "correct_answer": "C. Orientation, recall, and language",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Orientation, recall, and language</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hallucinations and delusions are typically assessed during the psychiatric history and mental status examination but are not specifically evaluated by the MMSE. These symptoms can be relevant in dementia, particularly in conditions like Lewy body dementia, but the MMSE focuses on cognitive domains.</li><li>\u2022 Option A. Hallucinations and delusions</li><li>\u2022 assessed during the psychiatric history and mental status examination</li><li>\u2022 not specifically evaluated by the MMSE.</li><li>\u2022 Option B. Motor coordination and strength are important in a neurological examination but are not assessed by the MMSE , which focuses on cognitive functions rather than motor skills.</li><li>\u2022 Option B. Motor coordination and strength</li><li>\u2022 neurological examination but are not assessed by the MMSE</li><li>\u2022 Option D. Executive function and problem-solving abilities are crucial in cognitive assessments but are not directly measured by the MMSE . The MMSE includes tasks that may indirectly require some executive function, but it is not designed to comprehensively assess this domain. More detailed neuropsychological testing would be needed for a thorough evaluation of executive function and problem-solving skills.</li><li>\u2022 Option D. Executive function and problem-solving abilities</li><li>\u2022 cognitive assessments but are not directly measured by the MMSE</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Mini-Mental State Examination (MMSE) is a brief cognitive screening tool that assesses various cognitive domains , including orientation, registration, attention and calculation, recall, and language . It is widely used to assess cognitive impairment in patients with suspected dementia or other neurocognitive disorders. The maximum score on MMSE is 30, a score less than 24 is indicative of cognitive impairment.</li><li>\u27a4 Mini-Mental State Examination</li><li>\u27a4 cognitive screening tool that assesses various cognitive domains</li><li>\u27a4 orientation, registration, attention and calculation, recall, and language</li><li>\u27a4 maximum score on MMSE is 30, a score less than 24 is indicative of cognitive impairment.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 1065.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 1065.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "adb65271",
      "audio": ""
    },
    {
      "text": "A 76-year-old man presents to the clinic with a 6-month history of progressive cognitive decline, accompanied by visual hallucinations and episodes of motor rigidity. His wife reports that he has also been experiencing sudden falls and episodes of unresponsiveness lasting a few seconds. The neurologist suspects a specific type of dementia. Which of the following characteristics is most consistent with the suspected diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Prominent early memory loss",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fluctuating levels of alertness and attention",
          "correct": true
        },
        {
          "label": "C",
          "text": "Slow, shuffling gait",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rapid progression to severe dementia within a year",
          "correct": false
        }
      ],
      "correct_answer": "B. Fluctuating levels of alertness and attention",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Fluctuating levels of alertness and attention</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Prominent early memory loss is more characteristic of Alzheimer's disease , which typically begins with memory impairment , particularly in short-term memory , before progressing to other cognitive domains.</li><li>\u2022 Option A. Prominent early memory loss</li><li>\u2022 characteristic of Alzheimer's disease</li><li>\u2022 begins with memory impairment</li><li>\u2022 short-term memory</li><li>\u2022 Option C. Slow, shuffling gait is often associated with Parkinson's disease. While Parkinson's disease and LBD share some features, such as motor rigidity due to Lewy bodies , the cognitive symptoms and their pattern, especially the fluctuating cognition, are more indicative of LBD.</li><li>\u2022 Option C. Slow, shuffling gait</li><li>\u2022 Parkinson's disease.</li><li>\u2022 motor rigidity due to Lewy bodies</li><li>\u2022 Option D. Rapid progression to severe dementia within a year is less typical for LBD and might suggest a more aggressive or different neurological condition , such as Creutzfeldt-Jakob disease , a rare and rapidly progressive neurodegenerative disorder.</li><li>\u2022 Option D. Rapid progression to severe dementia within a year</li><li>\u2022 less typical for LBD and might suggest a more aggressive or different neurological condition</li><li>\u2022 Creutzfeldt-Jakob disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lewy body dementia (LBD) is characterized by fluctuating cognition with pronounced variations in attention and alertness , visual hallucinations , Parkinsonian motor symptoms , and autonomic dysfunction.</li><li>\u27a4 Lewy body dementia</li><li>\u27a4 fluctuating cognition with pronounced variations in attention and alertness</li><li>\u27a4 visual hallucinations</li><li>\u27a4 Parkinsonian motor symptoms</li><li>\u27a4 autonomic dysfunction.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 243.</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 243.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "47d3bdc5",
      "audio": ""
    },
    {
      "text": "A 58-year-old man presents to the clinic with his wife, who reports that he has experienced significant behavioral changes over the past year. She describes him as increasingly disinhibited, impulsive, and apathetic. The patient has also been making socially inappropriate remarks and has lost interest in his usual hobbies. His memory and orientation, however, seem to be relatively preserved. The physician is considering a diagnosis of a specific type of dementia. Which of the following types of dementia is most consistent with the patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vascular dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Frontotemporal dementia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lewy body dementia",
          "correct": false
        }
      ],
      "correct_answer": "C. Frontotemporal dementia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Frontotemporal dementia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alzheimer's disease primarily affects memory .</li><li>\u2022 Option A. Alzheimer's disease</li><li>\u2022 memory</li><li>\u2022 Option B. Vascular dementia is characterized by a stepwise decline in cognitive function due to cerebrovascular disease.</li><li>\u2022 Option B. Vascular dementia</li><li>\u2022 stepwise decline in cognitive function due to cerebrovascular disease.</li><li>\u2022 Option D. Lewy body dementia typically presents with cognitive fluctuations, visual hallucinations, and parkinsonian features.</li><li>\u2022 Option D. Lewy body dementia</li><li>\u2022 cognitive fluctuations, visual hallucinations, and parkinsonian features.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Frontotemporal dementia is characterized by degeneration of the frontal and/or temporal lobes , leading to significant changes in behavior, personality, and social conduct , with relative preservation of memory in the early stages . This distinguishes it from Alzheimer's disease, which primarily affects memory, and from other types of dementia, such as vascular dementia and Lewy body dementia, which have different hallmark symptoms.</li><li>\u27a4 Frontotemporal dementia</li><li>\u27a4 degeneration of the frontal and/or temporal lobes</li><li>\u27a4 changes in behavior, personality, and social conduct</li><li>\u27a4 preservation of memory in the early stages</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 243.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 243.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "578ee5bc",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman presents to the clinic with a 6-month history of progressive memory loss, difficulty in naming familiar objects, and getting lost while driving to familiar places. Her family history is notable for a father and two siblings who had similar symptoms in their late sixties. Given her family history, which of the following genes is most commonly associated with early-onset familial Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "SOD1",
          "correct": false
        },
        {
          "label": "B",
          "text": "HTT.",
          "correct": false
        },
        {
          "label": "C",
          "text": "APP.",
          "correct": true
        },
        {
          "label": "D",
          "text": "CFTR.",
          "correct": false
        }
      ],
      "correct_answer": "C. APP.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-170438.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/picture2_BjLHnRr.jpg"
      ],
      "explanation": "<p><strong>Ans. C) APP.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. SOD1: The SOD1 gene is associated with familial amyotrophic lateral sclerosis (ALS), not Alzheimer's disease.</li><li>\u2022 Option A. SOD1:</li><li>\u2022 associated with familial amyotrophic lateral sclerosis</li><li>\u2022 Option B. HTT: Mutations in the HTT gene lead to Huntington's disease, a progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms .</li><li>\u2022 Option B. HTT:</li><li>\u2022 lead to Huntington's disease, a progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms</li><li>\u2022 Option D. CFTR: The CFTR gene is associated with cystic fibrosis , an inherited disorder that causes severe damage to the lungs, digestive system, and other organs in the body.</li><li>\u2022 Option D. CFTR:</li><li>\u2022 associated with cystic fibrosis</li><li>\u2022 inherited disorder</li><li>\u2022 damage to the lungs, digestive system, and other organs in the body.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Early-onset familial Alzheimer's disease is associated with genetic mutations , most commonly in the APP, PSEN1, and PSEN2 genes , which lead to the production and accumulation of amyloid-beta peptides and the development of amyloid plaques , one of the pathologic hallmarks of Alzheimer's disease.</li><li>\u27a4 Early-onset familial Alzheimer's disease</li><li>\u27a4 genetic mutations</li><li>\u27a4 APP, PSEN1, and PSEN2 genes</li><li>\u27a4 production and accumulation of amyloid-beta peptides</li><li>\u27a4 development of amyloid plaques</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239-240.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239-240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "186e5e8c",
      "audio": ""
    },
    {
      "text": "A 65-year-old man is brought to the clinic by his daughter due to increasing forgetfulness over the past year. She is concerned about the possibility of him developing Alzheimer's disease (AD) as his mother had AD. She inquires about risk factors that might predispose him to the disease. Which of the following is a non-modifiable risk factor for Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "Hypertension.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Smoking.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Age of 65 years.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Male gender.",
          "correct": false
        }
      ],
      "correct_answer": "C. Age of 65 years.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Age.of 65 years</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Hypertension: Hypertension is a modifiable risk factor for Alzheimer's disease. Managing blood pressure through lifestyle changes and medication can help reduce the risk.</li><li>\u2022 Option A.  Hypertension:</li><li>\u2022 modifiable risk factor for Alzheimer's disease.</li><li>\u2022 Option B. Smoking: Smoking is also a modifiable risk factor . Quitting smoking can significantly reduce the risk of developing Alzheimer's disease.</li><li>\u2022 Option B. Smoking:</li><li>\u2022 modifiable risk factor</li><li>\u2022 Option D. Male gender: While some studies have suggested gender may influence the risk of AD, with women being at a higher risk perhaps due to longer life expectancy , age is still the most significant non-modifiable risk factor among the options provided.</li><li>\u2022 Option D. Male gender:</li><li>\u2022 women being at a higher risk perhaps due to longer life expectancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Non-modifiable risk factors for Alzheimer\u2019s disease include :</li><li>\u27a4 Non-modifiable risk factors for Alzheimer\u2019s disease include</li><li>\u27a4 Age- The most important risk factor Family history of Alzheimer\u2019s disease Female gender</li><li>\u27a4 Age- The most important risk factor</li><li>\u27a4 Family history of Alzheimer\u2019s disease</li><li>\u27a4 Female gender</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8ab4c504",
      "audio": ""
    },
    {
      "text": "A 58-year-old woman is seen in the clinic for a regular health check-up. She expresses concern about her risk of developing Alzheimer's disease (AD) as her maternal grandmother had the disease. She asks the physician about any controllable factors that could reduce her risk. Which of the following is a modifiable risk factor for Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "High education levels.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypotension.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Physical inactivity.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gender.",
          "correct": false
        }
      ],
      "correct_answer": "C. Physical inactivity.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Physical inactivity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. High education levels: Higher levels of education have been associated with a lower risk of AD .</li><li>\u2022 Option A. High education levels:</li><li>\u2022 associated with a lower risk of AD</li><li>\u2022 Option B. Hypotension: While hypotension (abnormally low blood pressure) can be a health concern , it is not typically listed as a modifiable risk factor for AD. Hypertension (high blood pressure), on the other hand, is a modifiable risk factor for AD.</li><li>\u2022 Option B. Hypotension:</li><li>\u2022 can be a health concern</li><li>\u2022 not typically listed as a modifiable risk factor for AD.</li><li>\u2022 Option D. Gender: Gender is a non-modifiable risk factor . Some studies suggest that women may be at a higher risk of developing AD, potentially related to longer life expectancy and hormonal changes after menopause.</li><li>\u2022 Option D. Gender:</li><li>\u2022 non-modifiable risk factor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Modifiable risk factors for Alzheimer\u2019s disease include :</li><li>\u27a4 Modifiable risk factors for Alzheimer\u2019s disease include</li><li>\u27a4 Head injury Physical inactivity Hypertension Insulin resistance Hyperlipidemia Depression Obesity Low education levels Social isolation</li><li>\u27a4 Head injury</li><li>\u27a4 Physical inactivity</li><li>\u27a4 Hypertension</li><li>\u27a4 Insulin resistance</li><li>\u27a4 Hyperlipidemia</li><li>\u27a4 Depression</li><li>\u27a4 Obesity</li><li>\u27a4 Low education levels</li><li>\u27a4 Social isolation</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b64a4111",
      "audio": ""
    },
    {
      "text": "A 75-year-old man is brought to the clinic by his son due to concerns about his cognitive decline. Over the past 18 months, the patient has become increasingly forgetful, often repeating the same questions several times within an hour. He has difficulty remembering recent events but recalls events from his youth quite vividly. On examination, his orientation to time is impaired, but he correctly identifies place and person. Based on the clinical presentation, which neuropathological finding is most likely to be seen in the above disease?",
      "options": [
        {
          "label": "A",
          "text": "Neurofibrillary tangles.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lewy bodies.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Multi-infarct areas in the brain.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Synuclein aggregates.",
          "correct": false
        }
      ],
      "correct_answer": "A. Neurofibrillary tangles.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-172322.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Neurofibrillary tangles.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Lewy bodies: These are intracytoplasmic inclusions , primarily composed of alpha-synuclein , found in Lewy body dementia and Parkinson's disease dementia, rather than in classic Alzheimer's disease.</li><li>\u2022 Option B. Lewy bodies:</li><li>\u2022 intracytoplasmic inclusions</li><li>\u2022 primarily composed of alpha-synuclein</li><li>\u2022 Option C. Multi-infarct areas in the brain: These are associated with vascular dementia, which occurs due to cumulative damage to the brain through multiple small strokes.</li><li>\u2022 Option C. Multi-infarct areas in the brain:</li><li>\u2022 associated with vascular dementia,</li><li>\u2022 occurs due to cumulative damage</li><li>\u2022 Option D. Synuclein aggregates: While synuclein is the primary component of Lewy bodies, its aggregates are not a feature of Alzheimer's disease but are associated with Lewy body dementia and Parkinson's disease dementia.</li><li>\u2022 Option D. Synuclein aggregates:</li><li>\u2022 primary component of Lewy bodies, its aggregates are not a feature of Alzheimer's disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Neurofibrillary tangles , composed of hyperphosphorylated tau protein , are a hallmark neuropathological finding in Alzheimer's disease.</li><li>\u27a4 Neurofibrillary tangles</li><li>\u27a4 hyperphosphorylated tau protein</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "120e5e82",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman is brought to the clinic by her son who expresses concern about her progressive forgetfulness. She often forgets recent conversations and misplaces objects around the house. Although initially alert and oriented, her son reports she has begun to forget the names of close relatives. Her past medical history is significant for hypertension and type 2 diabetes. The physician is considering the diagnosis of Alzheimer's disease (AD). Which of the following is the most definitive method for diagnosing AD?",
      "options": [
        {
          "label": "A",
          "text": "Positron emission tomography (PET) scan showing decreased glucose uptake in the brain.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mini-Mental State Examination (MMSE) score below 24.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cerebrospinal fluid analysis showing decreased beta-amyloid and increased tau proteins.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Postmortem histopathological examination of the brain.",
          "correct": true
        }
      ],
      "correct_answer": "D. Postmortem histopathological examination of the brain.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Postmortem histopathological examination of the brain.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Positron emission tomography (PET) scan showing decreased glucose uptake in the brain : While PET scans can show patterns of decreased glucose metabolism in areas of the brain typically affected by AD , this finding is not definitive for AD and can be seen in other types of dementia as well.</li><li>\u2022 Option A:</li><li>\u2022 Positron emission tomography</li><li>\u2022 scan</li><li>\u2022 decreased glucose uptake in the brain</li><li>\u2022 PET scans can show patterns of decreased glucose metabolism in areas of the brain typically affected by AD</li><li>\u2022 Option B: Mini-Mental State Examination (MMSE) score below 24 : The MMSE is a screening tool used to assess cognitive impairment . A score below 24 suggests cognitive impairment, but it is not specific to AD and cannot definitively diagnose the condition.</li><li>\u2022 Option B:</li><li>\u2022 Mini-Mental State Examination</li><li>\u2022 score below 24</li><li>\u2022 screening tool used to assess cognitive impairment</li><li>\u2022 Option C: Cerebrospinal fluid analysis showing decreased beta-amyloid and increased tau proteins : Abnormal levels of beta-amyloid and tau proteins in cerebrospinal fluid are indicative of AD , but this finding is not considered definitive for diagnosing AD. It can support the diagnosis when considered alongside clinical symptoms and other diagnostic tests.</li><li>\u2022 Option C:</li><li>\u2022 Cerebrospinal fluid analysis showing decreased beta-amyloid and increased tau proteins</li><li>\u2022 Abnormal levels of beta-amyloid</li><li>\u2022 tau proteins in cerebrospinal fluid are indicative of AD</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The definitive diagnosis of Alzheimer's disease can only be made through postmortem histopathological examination of the brain , which reveals characteristic neuropathological features such as amyloid-beta plaques and neurofibrillary tangles. While various clinical assessments and imaging studies can strongly suggest AD during a patient's life, they are not definitive.</li><li>\u27a4 definitive diagnosis of Alzheimer's disease</li><li>\u27a4 made through postmortem histopathological examination of the brain</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1e805842",
      "audio": ""
    },
    {
      "text": "A 74-year-old man presents to the clinic with a 6-month history of progressive cognitive decline. His daughter reports that he frequently has visual hallucinations and sometimes stares blankly for short periods. Additionally, she mentions episodes of unsteadiness and falls. His medical history is unremarkable. The physician suspects that his symptoms may not be indicative of Alzheimer's disease (AD). Which of the following features is more suggestive of Lewy Body Dementia (LBD) than AD?",
      "options": [
        {
          "label": "A",
          "text": "Memory impairment.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fluent aphasia.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Visual hallucinations.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Apraxia.",
          "correct": false
        }
      ],
      "correct_answer": "C. Visual hallucinations.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Visual hallucinations.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Memory impairment: While memory impairment is a hallmark of AD , it can also occur in LBD . However, in LBD, memory impairment tends to occur later in the disease progression compared to AD.</li><li>\u2022 Option A. Memory impairment:</li><li>\u2022 memory impairment is a hallmark of AD</li><li>\u2022 occur in LBD</li><li>\u2022 Option B. Fluent aphasia: Fluent aphasia is not typically a feature of LBD . Aphasia, when it occurs in dementia, is more often associated with Alzheimer's disease or other types of dementia.</li><li>\u2022 Option B. Fluent aphasia:</li><li>\u2022 not typically a feature of LBD</li><li>\u2022 Option D. Apraxia: Apraxia, the inability to perform purposeful movements or use objects correctly , is more commonly associated with Alzheimer's disease , though it can also occur in other types of dementia.</li><li>\u2022 Option D. Apraxia:</li><li>\u2022 inability to perform purposeful movements or use objects correctly</li><li>\u2022 commonly associated with Alzheimer's disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Recurrent and detailed visual hallucinations are more suggestive of Lewy Body Dementia (LBD) than Alzheimer's disease . LBD is also characterized by fluctuating cognition, parkinsonian features, and potential complications with neuroleptic medications. While memory impairment and apraxia can be seen in LBD, they are more characteristic of AD, especially in the early stages.</li><li>\u27a4 Recurrent and detailed visual hallucinations</li><li>\u27a4 suggestive of Lewy Body Dementia</li><li>\u27a4 than Alzheimer's disease</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 243.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 243.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d3cc8d95",
      "audio": ""
    },
    {
      "text": "Dr. Aarav, a psychiatrist in Hyderabad, was consulted regarding a 72-year-old man named Kishore. Kishore's daughter, Deepa, reported that over the past year, her father had episodes of visual hallucinations, often describing children playing in the room, though no one was present. She also noted fluctuations in his cognition, with \"good days\" where he seemed almost his usual self, interspersed with \"bad days\" where he appeared confused and disoriented. Additionally, Deepa mentioned that Kishore seemed stiffer when walking, often shuffling his feet. Dr. Aarav's examination also revealed a mild resting tremor in Kishore's right hand. Given the presentation, which condition is most likely?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parkinson's disease.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lewy body dementia.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Frontotemporal dementia.",
          "correct": false
        }
      ],
      "correct_answer": "C. Lewy body dementia.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Lewy body dementia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alzheimer's disease: While Alzheimer's disease is the most common cause of dementia in older adults , it usually presents with memory impairment as the initial and most prominent symptom . While some neuropsychiatric symptoms like hallucinations can occur, they are not as common as in LBD and do not typically dominate the clinical picture.</li><li>\u2022 Option A. Alzheimer's disease:</li><li>\u2022 Alzheimer's disease is the most common cause of dementia in older adults</li><li>\u2022 presents with memory impairment</li><li>\u2022 initial and most prominent symptom</li><li>\u2022 Option B. Parkinson's disease: Parkinson's disease primarily presents with motor symptoms, including bradykinesia, resting tremor, rigidity, and postural instability . Cognitive impairment can develop later in the course of the disease, but it typically does not show the same fluctuating pattern seen in LBD. Moreover, visual hallucinations are less common and tend to appear in the later stages, often in association with medication side effects.</li><li>\u2022 Option B. Parkinson's disease:</li><li>\u2022 primarily presents with motor symptoms,</li><li>\u2022 bradykinesia, resting tremor, rigidity, and postural instability</li><li>\u2022 Option D. Frontotemporal dementia: This form of dementia usually presents with changes in personality, behaviour, or language . Memory impairment is not a predominant feature, and visual hallucinations are not typical.</li><li>\u2022 Option D. Frontotemporal dementia:</li><li>\u2022 form of dementia usually presents with changes in personality, behaviour, or language</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lewy body dementia (Dementia with Lewy Body) is characterized by general symptoms of dementia and additional features which include:</li><li>\u27a4 Lewy body dementia</li><li>\u27a4 general symptoms of dementia</li><li>\u27a4 Fluctuating levels of attention and alertness Recurrent visual hallucinations Parkinsonian features (hence antipsychotics should be avoided)</li><li>\u27a4 Fluctuating levels of attention and alertness</li><li>\u27a4 Recurrent visual hallucinations</li><li>\u27a4 Parkinsonian features (hence antipsychotics should be avoided)</li><li>\u27a4 It is characterized by the presence of inclusion bodies in the neurons (known as Lewy bodies), composed of alpha-synuclein.</li><li>\u27a4 characterized by the presence of inclusion bodies in the neurons</li><li>\u27a4 composed of alpha-synuclein.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 243.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 243.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "95354fc1",
      "audio": ""
    },
    {
      "text": "A 68-year-old woman presents with progressive memory loss over the past two years. Her family mentions that she frequently misplaces items and struggles to recognize close relatives. The physician suspects an irreversible form of dementia. Which of the following is NOT classified as an irreversible dementia?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vascular dementia.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Frontotemporal dementia.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Normal Pressure Hydrocephalus.",
          "correct": true
        }
      ],
      "correct_answer": "D. Normal Pressure Hydrocephalus.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/picture3_E6cmnje.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Normal Pressure Hydrocephalus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alzheimer's disease: Alzheimer's disease is a common form of irreversible dementia characterized by progressive memory loss and cognitive decline due to neurodegenerative changes in the brain.</li><li>\u2022 Option A. Alzheimer's disease:</li><li>\u2022 common form of irreversible dementia</li><li>\u2022 progressive memory loss</li><li>\u2022 cognitive decline</li><li>\u2022 Option B. Vascular dementia: Vascular dementia, which results from cerebrovascular disease and stroke, is considered an irreversible form of dementia caused by brain damage from impaired blood flow.</li><li>\u2022 Option B. Vascular dementia:</li><li>\u2022 results from cerebrovascular disease and stroke,</li><li>\u2022 irreversible form of dementia caused by brain damage</li><li>\u2022 Option C. Frontotemporal dementia: Frontotemporal dementia is another irreversible form of dementia that affects the frontal and temporal lobes of the brain , leading to changes in personality, behaviour, and language.</li><li>\u2022 Option C. Frontotemporal dementia:</li><li>\u2022 irreversible form of dementia that affects the frontal and temporal lobes of the brain</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Normal Pressure Hydrocephalus , characterized by the triad of gait disturbances , urinary incontinence, and cognitive impairment, is a potentially reversible cause of dementia. It can be treated with surgical intervention , which may lead to improvement in symptoms. In contrast, Alzheimer's disease, vascular dementia, and frontotemporal dementia are typically irreversible forms of dementia.</li><li>\u27a4 Normal Pressure Hydrocephalus</li><li>\u27a4 triad of gait disturbances</li><li>\u27a4 urinary incontinence, and cognitive impairment, is a potentially reversible cause of dementia.</li><li>\u27a4 surgical intervention</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 237.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 237.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7e1a9a7",
      "audio": ""
    },
    {
      "text": "A 72-year-old male with a history of hypertension and multiple transient ischemic attacks presents with a gradual decline in cognitive function over the past year. On examination, he displays impaired judgment and difficulty with certain tasks. The patient's family reports that this cognitive decline is punctuated by periods where his symptoms seem to noticeably worsen. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Frontotemporal dementia.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lewy-Body Dementia.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vascular dementia.",
          "correct": true
        }
      ],
      "correct_answer": "D. Vascular dementia.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/picture4_BJuFzup.jpg"
      ],
      "explanation": "<p><strong>Ans. D.) Vascular dementia.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alzheimer's disease: Alzheimer's disease typically presents with a more gradual and continuous cognitive decline , often beginning with memory impairment . The stepwise progression described in the patient is less characteristic of Alzheimer's disease.</li><li>\u2022 Option A. Alzheimer's disease:</li><li>\u2022 presents with a more gradual and continuous cognitive decline</li><li>\u2022 beginning with memory impairment</li><li>\u2022 Option B. Frontotemporal dementia: This form of dementia often presents with early changes in personality and behaviour or language difficulties, rather than the pattern of cognitive decline seen in vascular dementia.</li><li>\u2022 Option B. Frontotemporal dementia:</li><li>\u2022 form of dementia often presents with early changes in personality and behaviour or language difficulties,</li><li>\u2022 Option C. Lewy-Body Dementia: Lewy-Body Dementia is characterized by fluctuations in cognitive function, visual hallucinations, and features of parkinsonism . While there can be fluctuations in cognitive ability, the patient's history of hypertension and TIAs points more towards vascular dementia.</li><li>\u2022 Option C. Lewy-Body Dementia:</li><li>\u2022 fluctuations in cognitive function, visual hallucinations, and features of parkinsonism</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vascular dementia , which is the second most common cause of dementia after Alzheimer's disease , is characterized by a stepwise decline in cognitive function , often associated with underlying cerebrovascular disease , such as hypertension or transient ischemic attacks . Each step or noticeable worsening typically corresponds to a new cerebrovascular event.</li><li>\u27a4 Vascular dementia</li><li>\u27a4 second most common cause of dementia after Alzheimer's disease</li><li>\u27a4 stepwise decline in cognitive function</li><li>\u27a4 underlying cerebrovascular disease</li><li>\u27a4 hypertension or transient ischemic attacks</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 242.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 242.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cecd3b16",
      "audio": ""
    },
    {
      "text": "An 80-year-old woman with a known diagnosis of Alzheimer's disease has been increasingly agitated and aggressive towards her caregivers over the past few weeks. The patient's daughter reports that these behavioral changes have made it difficult to care for her mother. No clear precipitating factor has been identified. The patient's current medications include donepezil and memantine. Which of the following is the most appropriate first-line management for this patient's behavioral symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Start haloperidol.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase the dose of memantine.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Implement non-pharmacologic interventions.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Begin sertraline.",
          "correct": false
        }
      ],
      "correct_answer": "C. Implement non-pharmacologic interventions.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Implement non-pharmacologic interventions.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Start haloperidol: Antipsychotic medications , such as haloperidol , are generally reserved for patients who pose a danger to themselves or others and have not responded to first-line treatments. They are associated with an increased risk of mortality in elderly patients with dementia.</li><li>\u2022 Option A. Start haloperidol:</li><li>\u2022 Antipsychotic medications</li><li>\u2022 haloperidol</li><li>\u2022 reserved for patients</li><li>\u2022 pose a danger to themselves</li><li>\u2022 Option B. Increase the dose of memantine: While memantine and other medications can be useful for the cognitive symptoms of dementia , they are not first-line treatments for behavioural symptoms.</li><li>\u2022 Option B. Increase the dose of memantine:</li><li>\u2022 memantine and other medications can be useful for the cognitive symptoms of dementia</li><li>\u2022 Option D.  Begin sertraline: SSRIs like sertraline can be considered in patients with BPSD , especially if depressive symptoms are present , but non-pharmacologic interventions should be tried first.</li><li>\u2022 Option D.  Begin sertraline:</li><li>\u2022 SSRIs like sertraline</li><li>\u2022 patients with BPSD</li><li>\u2022 depressive symptoms are present</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Non-pharmacologic interventions are the first-line management for behavioural and psychological symptoms associated with dementia.</li><li>\u27a4 Non-pharmacologic interventions</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 238.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 238.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8b06234b",
      "audio": ""
    },
    {
      "text": "A 65-year-old man, previously in good health, presents with profound dementia three months after undergoing a corneal transplant. His family reports a significant cognitive decline. During the examination, the patient exhibits myoclonic jerks. An electroencephalogram (EEG) is performed, revealing periodic bursts of electrical activity superimposed on a slow background. Based on the patient's history and presentation, what is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Wilson disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vascular dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Creutzfeldt-Jakob disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pseudodementia",
          "correct": false
        }
      ],
      "correct_answer": "C. Creutzfeldt-Jakob disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Creutzfeldt-Jakob disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Wilson disease: This is a genetic disorder affecting copper metabolism, leading to copper accumulation and associated neurological and psychiatric symptoms. It typically presents earlier in life and does not match the rapid progression and EEG findings seen in this case.</li><li>\u2022 Option A. Wilson disease:</li><li>\u2022 genetic disorder affecting copper metabolism,</li><li>\u2022 copper accumulation</li><li>\u2022 Option B. Vascular dementia: This results from cerebrovascular disease and usually has a more gradual onset and stepwise progression , unlike the rapid decline seen in CJD.</li><li>\u2022 Option B. Vascular dementia:</li><li>\u2022 cerebrovascular disease and usually has a more gradual onset and stepwise progression</li><li>\u2022 Option D. Pseudodementia: This term is used to describe a situation where a severe psychiatric illness, such as depression, mimics the symptoms of dementia. The rapid cognitive decline and EEG findings in this case are not typical of pseudodementia.</li><li>\u2022 Option D. Pseudodementia:</li><li>\u2022 rapid cognitive decline and EEG findings in this case are not typical of pseudodementia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Creutzfeldt-Jakob disease is characterized by rapidly progressive dementia , myoclonic jerks, seizures and cerebellar ataxia . EEG usually shows periodic sharp wave complexes with slow background.</li><li>\u27a4 Creutzfeldt-Jakob disease</li><li>\u27a4 rapidly progressive dementia</li><li>\u27a4 myoclonic jerks, seizures and cerebellar ataxia</li><li>\u27a4 Ref : Kaplan & Sadock Comprehensive Textbook of Psychiatry, 10th edition, Page 597.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock Comprehensive Textbook of Psychiatry, 10th edition, Page 597.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72bbf3a0",
      "audio": ""
    },
    {
      "text": "Which of the following neurodegenerative diseases is most commonly associated with symptoms resembling schizophrenia?",
      "options": [
        {
          "label": "A",
          "text": "Pick\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Creutzfeldt\u2013Jakob disease (CJD)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Huntington\u2019s dementia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Vacular dementia",
          "correct": false
        }
      ],
      "correct_answer": "C. Huntington\u2019s dementia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Huntington\u2019s dementia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pick\u2019s disease: Also known as frontotemporal dementia , it primarily presents with changes in personality and behavior, and language difficulties, rather than symptoms resembling schizophrenia.</li><li>\u2022 Option A. Pick\u2019s disease:</li><li>\u2022 frontotemporal dementia</li><li>\u2022 presents with changes in personality and behavior,</li><li>\u2022 Option B. Creutzfeldt\u2013Jakob disease (CJD): A rapidly progressive and fatal neurodegenerative disorder , CJD typically presents with rapidly declining mental function and movement problems. Schizophrenia-like symptoms are not a hallmark of this disease.</li><li>\u2022 Option B. Creutzfeldt\u2013Jakob disease (CJD):</li><li>\u2022 rapidly progressive</li><li>\u2022 fatal neurodegenerative disorder</li><li>\u2022 CJD</li><li>\u2022 rapidly declining mental function and movement problems.</li><li>\u2022 Option D. Vascular dementia: Caused by impaired blood flow to the brain , vascular dementia typically presents with cognitive impairments related to reasoning, planning, judgment, memory, and other thought processes . It is less commonly associated with schizophrenia-like symptoms.</li><li>\u2022 Option D. Vascular dementia:</li><li>\u2022 impaired blood flow to the brain</li><li>\u2022 vascular dementia</li><li>\u2022 cognitive impairments related to reasoning, planning, judgment, memory, and other thought processes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Huntington's disease is inherited in an autosomal dominant manner . This neurodegenerative disorder is associated with the expansion of a trinucleotide repeat sequence on the chromosome 4p . It is characterized by a triad of: choreic movements , cognitive decline , and psychiatric syndromes . It usually manifests in the fourth to fifth decade. The psychiatric presentation is often variable and may precede motor and cognitive changes. The most common psychiatric issues include personality changes (such as impulsiveness, disinhibition, and dissocial behavior) and depression. Paranoid schizophrenia-like symptoms occur in around 25% of cases. Such schizophrenia-like presentations are very rare in other conditions listed.</li><li>\u27a4 Huntington's disease</li><li>\u27a4 autosomal dominant manner</li><li>\u27a4 neurodegenerative disorder</li><li>\u27a4 expansion of a trinucleotide repeat sequence on the chromosome 4p</li><li>\u27a4 choreic movements</li><li>\u27a4 cognitive decline</li><li>\u27a4 psychiatric syndromes</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 244.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 244.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "14476547",
      "audio": ""
    },
    {
      "text": "In the treatment of which condition are cholinesterase inhibitors generally considered ineffective?",
      "options": [
        {
          "label": "A",
          "text": "Lewy body dementia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mixed dementia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Frontotemporal dementia (FTD)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Early-onset dementia of Alzheimer\u2019s type",
          "correct": false
        }
      ],
      "correct_answer": "C. Frontotemporal dementia (FTD)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Frontotemporal dementia (FTD)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Lewy body dementia: Patients with Lewy body dementia may benefit from cholinesterase inhibitors , as they often have a cholinergic deficit.</li><li>\u2022 Option A.  Lewy body dementia:</li><li>\u2022 Lewy body dementia may benefit from cholinesterase inhibitors</li><li>\u2022 Option B. Mixed dementia: In cases involving Alzheimer's pathology, cholinesterase inhibitors might be beneficial due to the Alzheimer's component .</li><li>\u2022 Option B. Mixed dementia:</li><li>\u2022 Alzheimer's pathology, cholinesterase inhibitors might be beneficial due to the Alzheimer's component</li><li>\u2022 Option D. Early-onset dementia of Alzheimer\u2019s type: Cholinesterase inhibitors are often used in Alzheimer\u2019s disease, including early-onset types , as they help address the acetylcholine deficiency associated with this condition.</li><li>\u2022 Option D. Early-onset dementia of Alzheimer\u2019s type:</li><li>\u2022 Cholinesterase inhibitors</li><li>\u2022 Alzheimer\u2019s disease, including early-onset types</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cholinesterase inhibitors are generally ineffective in the treatment of frontotemporal dementia (FTD), as the pathology of FTD is not related to a deficiency of acetylcholine , which these drugs target. In contrast, FTD occurs due to neuronal degeneration of frontal and temporal lobes of the brain.</li><li>\u27a4 Cholinesterase inhibitors</li><li>\u27a4 ineffective in the treatment of frontotemporal dementia</li><li>\u27a4 pathology of FTD is not related to a deficiency of acetylcholine</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 243.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 243.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "07c4580e",
      "audio": ""
    },
    {
      "text": "An 82-year-old woman is admitted to the hospital for a hip fracture. On the second day of admission, the nursing staff notes that the patient appears disoriented and is having difficulty focusing during conversations. Her medications include metoprolol, furosemide, and omeprazole. The patient\u2019s daughter reports that she was completely oriented and had no cognitive issues before the hospitalization. Which of the following is the most likely cause of the patient's current condition?",
      "options": [
        {
          "label": "A",
          "text": "Progression of a previously undiagnosed Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adverse effect of her current medications.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Delirium due to hospitalization.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Onset of a major depressive episode.",
          "correct": false
        }
      ],
      "correct_answer": "C. Delirium due to hospitalization.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Delirium due to hospitalization</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Progression of a previously undiagnosed Alzheimer's disease: Alzheimer's disease and other dementias have a gradual onset and would not present acutely .</li><li>\u2022 Option A. Progression of a previously undiagnosed Alzheimer's disease:</li><li>\u2022 Alzheimer's disease</li><li>\u2022 other dementias</li><li>\u2022 gradual onset and would not present acutely</li><li>\u2022 Option B.  Adverse effect of her current medications: While medications can be a cause of delirium , the patient was on these medications prior to admission and was without cognitive issues.</li><li>\u2022 Option B.  Adverse effect of her current medications:</li><li>\u2022 medications</li><li>\u2022 cause of delirium</li><li>\u2022 Option D. Onset of a major depressive episode: A major depressive episode typically doesn't present with acute disorientation and fluctuating attention . It would present with persistent depressive mood, anhedonia, and other characteristic symptoms.</li><li>\u2022 Option D. Onset of a major depressive episode:</li><li>\u2022 major depressive episode</li><li>\u2022 doesn't present with acute disorientation</li><li>\u2022 fluctuating attention</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delirium is characterized by sudden onset & fluctuating course and presents with disturbances of consciousness (hallmark symptom), disorientation to time , place and person , perceptual disturbances like illusions and hallucinations , impairment of attention, memory disturbances (recent and immediate, remote is intact), agitation (or hypoactivity), autonomic disturbances, sleep-wake cycle disturbances and sundowning phenomenon. Causes include:</li><li>\u27a4 Delirium</li><li>\u27a4 sudden onset & fluctuating course and presents with disturbances of consciousness</li><li>\u27a4 disorientation to time</li><li>\u27a4 place and person</li><li>\u27a4 perceptual disturbances like illusions and hallucinations</li><li>\u27a4 Medical and surgical disorders/in hospitalised patients. Hip fractures, open heart surgery, severe burns, infections like pneumonia, postoperative patients, critically ill patients Alcohol and sedatives withdrawal On multiple medications (especially with anticholinergic actions) Sensory deprivation (e.g. Black patch delirium after cataract surgery)</li><li>\u27a4 Medical and surgical disorders/in hospitalised patients.</li><li>\u27a4 Hip fractures, open heart surgery, severe burns, infections like pneumonia, postoperative patients, critically ill patients</li><li>\u27a4 Alcohol and sedatives withdrawal</li><li>\u27a4 On multiple medications (especially with anticholinergic actions)</li><li>\u27a4 Sensory deprivation (e.g. Black patch delirium after cataract surgery)</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 232.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 232.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83a4673b",
      "audio": ""
    },
    {
      "text": "A 76-year-old man presents with a 1-day history of confusion, inattention, and fluctuating levels of consciousness. His daughter mentions that he has been picking at his bed linens and seems to see things that are not present. Given the acute onset of his symptoms, delirium is suspected. Which neurotransmitter and brain area are primarily implicated in the pathophysiology of delirium?",
      "options": [
        {
          "label": "A",
          "text": "Serotonin, Raphe nucleus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dopamine, Ventral tegmental area",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetylcholine, Ascending Reticular Activating System",
          "correct": true
        },
        {
          "label": "D",
          "text": "GABA, Nucleus accumbens",
          "correct": false
        }
      ],
      "correct_answer": "C. Acetylcholine, Ascending Reticular Activating System",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Acetylcholine, Ascending Reticular Activating System</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Serotonin, Raphe nucleus: While serotonin is associated with mood regulation and is involved in many psychiatric conditions like depression, it's not the primary neurotransmitter implicated in the pathophysiology of delirium .</li><li>\u2022 Option A.  Serotonin, Raphe nucleus:</li><li>\u2022 serotonin</li><li>\u2022 not the primary neurotransmitter implicated in the pathophysiology of delirium</li><li>\u2022 Option B. Dopamine, Ventral tegmental area: Dopamine dysfunction can contribute to various psychiatric and neurologic disorders (e.g., schizophrenia, Parkinson's disease), but it's not the primary neurotransmitter associated with delirium.</li><li>\u2022 Option B. Dopamine, Ventral tegmental area:</li><li>\u2022 Dopamine dysfunction</li><li>\u2022 psychiatric and neurologic disorders</li><li>\u2022 Option D. GABA, Nucleus acumens: GABAergic pathways are crucial for various neurologic functions , including the modulation of anxiety and the actions of several aesthetic agents , but they are not primarily associated with the pathophysiology of delirium.</li><li>\u2022 Option D. GABA, Nucleus acumens:</li><li>\u2022 GABAergic pathways</li><li>\u2022 various neurologic functions</li><li>\u2022 modulation of anxiety and the actions of several aesthetic agents</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Delirium is associated with cholinergic deficiency, primarily involving the Ascending Reticular Activating System.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 227.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "76279704",
      "audio": ""
    },
    {
      "text": "A 78-year-old man, post-operative from a hip replacement surgery, starts to display fluctuating levels of consciousness, poor attention, and visual hallucinations. He becomes increasingly agitated and tries to remove his IV lines. His clinical diagnosis is consistent with delirium. Which of the following pharmacological interventions is most appropriate to manage his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Diazepam 10 mg orally.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Haloperidol 0.5 mg orally.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Donepezil 10 mg orally.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amitriptyline 25 mg orally.",
          "correct": false
        }
      ],
      "correct_answer": "B. Haloperidol 0.5 mg orally.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Haloperidol 0.5 mg orally.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Diazepam 10 mg orally: Benzodiazepines , such as diazepam, can exacerbate or induce delirium, especially in the elderly . Their use is generally reserved for cases where the delirium is due to alcohol or benzodiazepine withdrawal.</li><li>\u2022 Option A. Diazepam 10 mg orally:</li><li>\u2022 Benzodiazepines</li><li>\u2022 can exacerbate or induce delirium,</li><li>\u2022 elderly</li><li>\u2022 Option C. Donepezil 10 mg orally: Donepezil is an acetylcholinesterase inhibitor used primarily in Alzheimer's disease. While cholinergic pathways are thought to be involved in delirium, donepezil is not recommended for the treatment of delirium as evidence of its efficacy is lacking.</li><li>\u2022 Option C. Donepezil 10 mg orally:</li><li>\u2022 Donepezil</li><li>\u2022 acetylcholinesterase inhibitor</li><li>\u2022 Alzheimer's disease.</li><li>\u2022 Option D. Amitriptyline 25 mg orally: Amitriptyline has anticholinergic properties and can exacerbate or induce delirium . It is not indicated in the management of delirium.</li><li>\u2022 Option D. Amitriptyline 25 mg orally:</li><li>\u2022 Amitriptyline</li><li>\u2022 anticholinergic properties and can exacerbate or induce delirium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Low-dose antipsychotics , such as haloperidol , are often used to control severe agitation or hallucinations associated with delirium . However, the underlying cause of delirium should always be addressed, and non-pharmacological interventions are fundamental to management.</li><li>\u27a4 Low-dose antipsychotics</li><li>\u27a4 haloperidol</li><li>\u27a4 used to control severe agitation or hallucinations associated with delirium</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 228.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 228.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d4fb7845",
      "audio": ""
    },
    {
      "text": "A 52-year-old woman presents to the outpatient clinic with a 6-month history of memory disturbances. On assessment, she is found to have an isolated memory deficit with the preservation of other cognitive functions. She reports having difficulty recalling recent events and conversations. Physical examination and laboratory investigations are within normal limits. Her symptoms most likely represent which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amnestic syndrome.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Normal aging.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Delirium.",
          "correct": false
        }
      ],
      "correct_answer": "B. Amnestic syndrome.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Amnestic syndrome.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Alzheimer's disease: While Alzheimer's disease does involve memory impairment , it also affects other cognitive domains such as executive functions , language, and visuospatial abilities. The isolated memory deficit described in the vignette is not typical of Alzheimer's disease.</li><li>\u2022 Option A.  Alzheimer's disease:</li><li>\u2022 Alzheimer's disease does involve memory impairment</li><li>\u2022 affects other cognitive domains such as executive functions</li><li>\u2022 Option C. Normal aging: While memory can decline somewhat with age, the severity of the memory impairment described in the vignette goes beyond what would be expected for normal aging.</li><li>\u2022 Option C. Normal aging:</li><li>\u2022 severity of the memory impairment described in the vignette goes beyond</li><li>\u2022 Option D. Delirium: Delirium typically presents with an acute onset and involves fluctuating levels of consciousness, attentional deficits, and a range of cognitive impairments . The presentation described does not align with delirium.</li><li>\u2022 Option D. Delirium:</li><li>\u2022 Delirium</li><li>\u2022 presents with an acute onset and involves fluctuating levels of consciousness, attentional deficits, and a range of cognitive impairments</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amnestic Disorders present with amnesia (anterograde and retrograde). Short-term and recent memory are usually impacted , and remote and immediate memory are preserved. Major causes include:</li><li>\u27a4 Amnestic Disorders</li><li>\u27a4 amnesia</li><li>\u27a4 Short-term and recent memory are usually impacted</li><li>\u27a4 Thiamine deficiency Hypoglycemia Primary brain conditions (head trauma, seizures, cerebral tumors, cerebrovascular disease, hypoxia, electroconvulsive therapy, multiple sclerosis) Substance-related disorders (alcohol, benzodiazepines)</li><li>\u27a4 Thiamine deficiency</li><li>\u27a4 Hypoglycemia</li><li>\u27a4 Primary brain conditions (head trauma, seizures, cerebral tumors, cerebrovascular disease, hypoxia, electroconvulsive therapy, multiple sclerosis)</li><li>\u27a4 Substance-related disorders (alcohol, benzodiazepines)</li><li>\u27a4 Ref: Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 245-246.</li><li>\u27a4 Ref:</li><li>\u27a4 Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 245-246.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5fc55c8e",
      "audio": ""
    },
    {
      "text": "A 45-year-old man is brought to the clinic by his wife, who reports that he has undergone significant behavioral changes over the past year. She describes him as being apathetic, socially disinhibited, and making impulsive decisions that are out of character. He also seems to have difficulty planning and organizing tasks. Neurological examination does not reveal any motor or sensory deficits. Based on these findings, the most likely location of a lesion or dysfunction in this patient's brain is:",
      "options": [
        {
          "label": "A",
          "text": "Temporal lobe.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parietal lobe.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Frontal lobe.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Occipital lobe.",
          "correct": false
        }
      ],
      "correct_answer": "C. Frontal lobe.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/13/screenshot-2024-03-13-180339.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Frontal lobe.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Temporal lobe: Dysfunction in the temporal lobe typically presents with problems related to memory, language, and sometimes seizures . The behavioral changes described are not typical of temporal lobe lesions.</li><li>\u2022 Option A. Temporal lobe:</li><li>\u2022 Dysfunction</li><li>\u2022 temporal lobe typically presents with problems related to memory, language, and sometimes seizures</li><li>\u2022 Option B. Parietal lobe: The parietal lobe is involved in processing sensory information and spatial orientation . Deficits here might lead to issues with sensation, spatial awareness, or difficulties in performing tasks that require spatial coordination (apraxia), which are not described in this scenario.</li><li>\u2022 Option B. Parietal lobe:</li><li>\u2022 parietal lobe is involved in processing sensory information and spatial orientation</li><li>\u2022 Option D. Occipital lobe: The occipital lobe is primarily involved in visual processing . Lesions in the occipital lobe typically result in visual disturbances, which are not mentioned in this case.</li><li>\u2022 Option D. Occipital lobe:</li><li>\u2022 occipital lobe</li><li>\u2022 involved in visual processing</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Frontal lobe syndrome is characterized by behavioral changes, including apathy, impulsivity, social disinhibition, and difficulty with planning and organization.</li><li>\u27a4 Frontal lobe syndrome</li><li>\u27a4 behavioral changes, including apathy, impulsivity, social disinhibition, and difficulty with planning and organization.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 254.</li><li>\u27a4 Ref</li><li>\u27a4 : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 254.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "15f48107",
      "audio": ""
    },
    {
      "text": "A 70-year-old retired teacher visits the clinic reporting instances of memory loss. To diagnose mild cognitive impairment (MCI) in this individual, which of the following is not a necessary criterion?",
      "options": [
        {
          "label": "A",
          "text": "Reporting of memory issues by the patient",
          "correct": false
        },
        {
          "label": "B",
          "text": "Demonstrable memory deficits for their age",
          "correct": false
        },
        {
          "label": "C",
          "text": "Retention of normal day-to-day functioning",
          "correct": false
        },
        {
          "label": "D",
          "text": "A family history of dementia",
          "correct": true
        }
      ],
      "correct_answer": "D. A family history of dementia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) A family history of dementia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Reporting of memory issues by the patient: This involves the individual's awareness and complaint of memory issues .</li><li>\u2022 Option A. Reporting of memory issues by the patient:</li><li>\u2022 individual's awareness and complaint of memory issues</li><li>\u2022 Option B. Demonstrable memory deficits for their age: This is usually confirmed through cognitive testing , which demonstrates memory impairment more than expected for the patient's age and educational background.</li><li>\u2022 Option B. Demonstrable memory deficits for their age:</li><li>\u2022 confirmed through cognitive testing</li><li>\u2022 Option C.  Retention of normal day-to-day functioning: Despite memory issues, individuals with MCI maintain their independence in daily activities . The deficits are not significant enough to impair their daily functioning, which differentiates MCI from dementia.</li><li>\u2022 Option C.  Retention of normal day-to-day functioning:</li><li>\u2022 individuals with MCI maintain their independence in daily activities</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 MCI Criteria proposed by the Mayo Clinic Alzheimer's Disease Research Centre (MCADRC):</li><li>\u27a4 MCI Criteria proposed by the Mayo Clinic Alzheimer's Disease Research Centre</li><li>\u27a4 Memory complaint, preferably qualified by an informant Memory impairment for age and education Preserved general cognitive function Intact activities of daily living Not demented</li><li>\u27a4 Memory complaint, preferably qualified by an informant</li><li>\u27a4 Memory impairment for age and education</li><li>\u27a4 Preserved general cognitive function</li><li>\u27a4 Intact activities of daily living</li><li>\u27a4 Not demented</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 262.</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page 262.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f82f72c",
      "audio": ""
    },
    {
      "text": "A 25-year-old man presents to the clinic complaining of frontal headaches. His medical history is significant for complex partial seizures. He describes a typical seizure beginning with 20 seconds of involuntary orobuccal movements. This is followed by approximately 40 seconds during which he experiences altered consciousness. Notably, at the onset of his seizures, he reports a compelling and uncontrollable urge to repeatedly think of the word \u2018Prashamsansan.\u2019 He is unable to suppress this thought, which persists throughout the seizure episode. His neurological examination and routine blood work are unremarkable. An MRI of the brain shows no structural abnormalities. What is this phenomenon called?",
      "options": [
        {
          "label": "A",
          "text": "Forced thinking",
          "correct": true
        },
        {
          "label": "B",
          "text": "Obsession",
          "correct": false
        },
        {
          "label": "C",
          "text": "Compulsion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Forced normalization",
          "correct": false
        }
      ],
      "correct_answer": "A. Forced thinking",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Forced thinking</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Obsession: While obsessions, as seen in Obsessive-Compulsive Disorder (OCD), are also characterized by repetitive thoughts, they are not limited to seizure episodes and typically persist outside of such episodes . The patient's experience is specifically tied to his seizure activity.</li><li>\u2022 Option B. Obsession:</li><li>\u2022 Obsessive-Compulsive Disorder</li><li>\u2022 repetitive thoughts, they are not limited to seizure episodes and typically persist outside of such episodes</li><li>\u2022 Option C. Compulsion: Compulsions involve repetitive behaviors or mental acts in response to an obsession. The patient's experience does not describe a behavior or mental act performed in response to an obsession; rather, it is an involuntary thought process occurring during seizures.</li><li>\u2022 Option C. Compulsion:</li><li>\u2022 repetitive behaviors or mental acts in response to an obsession.</li><li>\u2022 Option D. Forced normalization: This term refers to a phenomenon where the EEG (electroencephalogram) patterns of a patient with epilepsy become normalized or less abnormal , typically in the context of an increase in psychiatric symptoms. It does not relate to the specific symptom described by the patient.</li><li>\u2022 Option D. Forced normalization:</li><li>\u2022 phenomenon where the EEG</li><li>\u2022 patterns of a patient with epilepsy become normalized or less abnormal</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Forced thinking is a type of psychic aura which is characterized by recurrent intrusive thoughts , or ideas, which subside on seizure activity.</li><li>\u27a4 Forced thinking</li><li>\u27a4 type of psychic aura</li><li>\u27a4 characterized by recurrent intrusive thoughts</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 510 .</li><li>\u27a4 Ref : Kaplan & Sadock\u2019s Comprehensive Textbook of Psychiatry, 10th edition, Page No 510</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a1486438",
      "audio": ""
    }
  ]
}